These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38359663)

  • 1. Inhibition of PKM2 suppresses osteoclastogenesis and alleviates bone loss in mouse periodontitis.
    Li F; Liu X; Li M; Wu S; Le Y; Tan J; Zhu C; Wan Q
    Int Immunopharmacol; 2024 Mar; 129():111658. PubMed ID: 38359663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRC5 modulates bone metabolism and plays a role in periodontitis.
    Wang W; Liu W; Liu J; Lv P; Wang Y; Ouyang X
    J Periodontal Res; 2022 Aug; 57(4):891-903. PubMed ID: 35734971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways.
    Chen K; Yan Z; Wang Y; Yang Y; Cai M; Huang C; Li B; Yang M; Zhou X; Wei X; Yang C; Chen Z; Zhai X; Li M
    Biomed Pharmacother; 2020 Jun; 126():110067. PubMed ID: 32272431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glipizide Alleviates Periodontitis Pathogenicity via Inhibition of Angiogenesis, Osteoclastogenesis and M1/M2 Macrophage Ratio in Periodontal Tissue.
    Guo X; Huang Z; Ge Q; Yang L; Liang D; Huang Y; Jiang Y; Pathak JL; Wang L; Ge L
    Inflammation; 2023 Oct; 46(5):1917-1931. PubMed ID: 37289398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic administration of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)-Ig abrogates alveolar bone resorption in induced periodontitis through inhibition of osteoclast differentiation and activation: An experimental investigation.
    Nakane S; Imamura K; Hisanaga R; Ishihara K; Saito A
    J Periodontal Res; 2021 Oct; 56(5):972-981. PubMed ID: 34129238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway.
    Dai Y; Liu Y; Li J; Jin M; Yang H; Huang G
    Bioengineered; 2022 May; 13(5):13906-13918. PubMed ID: 35706397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel adiponectin receptor agonist (AdipoAI) ameliorates type 2 diabetes-associated periodontitis by enhancing autophagy in osteoclasts.
    Wu X; Sun Y; Cui R; Qiu W; Zhang J; Hu Z; Bi W; Yang F; Ma D; Van Dyke T; Tu Q; Yu Y; Chen J
    J Periodontal Res; 2022 Apr; 57(2):381-391. PubMed ID: 34984683
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Ma XX; Meng XQ; Wang YL; Liu Y; Shi XR; Shao S; Duan SZ; Lu HX
    J Dent Res; 2023 Jan; 102(1):72-81. PubMed ID: 35983582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yunnan Baiyao Inhibits Periodontitis by Suppressing the Autophagic Flux.
    Li Y; Liu W; Zhao R; An Y; Zhang M; Ren X; He H
    Int Dent J; 2024 Apr; 74(2):284-293. PubMed ID: 37852809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micromolar sodium fluoride mediates anti-osteoclastogenesis in Porphyromonas gingivalis-induced alveolar bone loss.
    Bhawal UK; Lee HJ; Arikawa K; Shimosaka M; Suzuki M; Toyama T; Sato T; Kawamata R; Taguchi C; Hamada N; Nasu I; Arakawa H; Shibutani K
    Int J Oral Sci; 2015 Dec; 7(4):242-9. PubMed ID: 26674426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dec2 negatively regulates bone resorption in periodontitis.
    Li X; Guo L; Sato F; Kitayama T; Tewari N; Makishima M; Hamada N; Liu Y; Bhawal UK
    J Periodontal Res; 2022 Oct; 57(5):1056-1069. PubMed ID: 35989621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin‑17A facilitates osteoclast differentiation and bone resorption via activation of autophagy in mouse bone marrow macrophages.
    Song L; Tan J; Wang Z; Ding P; Tang Q; Xia M; Wei Y; Chen L
    Mol Med Rep; 2019 Jun; 19(6):4743-4752. PubMed ID: 31059030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AZD8835 inhibits osteoclastogenesis and periodontitis-induced alveolar bone loss in rats.
    Wang Y; Chen X; Chen X; Zhou Z; Xu W; Xu F; Zhang S
    J Cell Physiol; 2019 Jul; 234(7):10432-10444. PubMed ID: 30652303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant thrombomodulin lectin-like domain attenuates Porphyromonas gingivalis lipopolysaccharide-induced osteoclastogenesis and periodontal bone resorption.
    Chang LY; Lai CH; Kuo CH; Chang BI; Wu HL; Cheng TL
    J Periodontol; 2021 Nov; 92(11):1622-1634. PubMed ID: 33438207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line.
    Yang W; Liu J; Hou L; Chen Q; Liu Y
    Life Sci; 2021 Jan; 265():118796. PubMed ID: 33220292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 2 activation primes and upregulates osteoclastogenesis via lox-1.
    Ohgi K; Kajiya H; Goto-T K; Okamoto F; Yoshinaga Y; Okabe K; Sakagami R
    Lipids Health Dis; 2018 Jun; 17(1):132. PubMed ID: 29859535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porphyromonas gingivalis-derived lysine gingipain enhances osteoclast differentiation induced by tumor necrosis factor-α and interleukin-1β but suppresses that by interleukin-17A: importance of proteolytic degradation of osteoprotegerin by lysine gingipain.
    Akiyama T; Miyamoto Y; Yoshimura K; Yamada A; Takami M; Suzawa T; Hoshino M; Imamura T; Akiyama C; Yasuhara R; Mishima K; Maruyama T; Kohda C; Tanaka K; Potempa J; Yasuda H; Baba K; Kamijo R
    J Biol Chem; 2014 May; 289(22):15621-30. PubMed ID: 24755218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rb3 inhibits osteoclastogenesis via ERK/NF-κB signaling pathway in vitro and in vivo.
    Sun M; Ji Y; Zhou S; Chen R; Yao H; Du M
    Oral Dis; 2023 Nov; 29(8):3460-3471. PubMed ID: 35976062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis.
    Zhao X; Zhu Y; Hu J; Jiang L; Li L; Jia S; Zen K
    Sci Rep; 2018 Sep; 8(1):14517. PubMed ID: 30266938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKM2 inhibitor shikonin suppresses TPA-induced mitochondrial malfunction and proliferation of skin epidermal JB6 cells.
    Li W; Liu J; Zhao Y
    Mol Carcinog; 2014 May; 53(5):403-12. PubMed ID: 23255458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.